Larimar Therapeutics
LRMR • NASDAQ
Larimar Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carole S. Ben-Maimon, with a market cap of $479.9M.
Market Cap$479.9M
Employees42.0
CEOCarole S. Ben-Maimon
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 29, 2026 · In 2 weeksQ1 2026
Financials
LRM
Larimar Therapeutics FAQ
Common questions about Larimar Therapeutics
Larimar Therapeutics is scheduled to report earnings for Q1 2026 on April 29, 2026.
Larimar Therapeutics has approximately 42 employees.